We have the pleasure to offer you the 3rd Part of our 2021 Collection dedicated to Smart Pharma Consulting publications regarding Medical Affairs & Marketing, following the 1st part dedicated to Pharma Market Insights and the 2nd part dedicated to Strategy & Market Access.
News
With 3 million people affected in France, rare diseases are a major public health issue. 25% of...
This position paper covers the following key issues:
French health authorities intent – cautiously – to facilitate the development of the biosimilars market by: This...